Article Text

other Versions

PDF
Pedunculopontine nucleus deep brain stimulation produces sustained improvement in primary progressive freezing of gait
  1. Robert A Wilcox1,2,
  2. Michael H Cole3,
  3. David Wong4,
  4. Terry Coyne1,
  5. Peter Silburn5,
  6. Graham Kerr3
  1. 1Saint Andrew's Memorial Hospital, Brisbane, Australia
  2. 2Comprehensive Movement Disorder Service, Neurology Department, Flinders Medical Centre, Bedford Park, Australia
  3. 3Movement Neuroscience Program, Institute of Health & Biomedical Innovation, Queensland University of Technology, Kelvin Grove, Brisbane, Australia
  4. 4The Wesley PET Centre, Wesley Hospital, Auchenflower, Brisbane, Australia
  5. 5University of Queensland Centre for Clinical Research, Royal Brisbane and Women's Hospital, University of Queensland, Herston, Brisbane, Australia
  1. Correspondence to Dr Robert Wilcox, Comprehensive Movement Disorder Service, Neurology Department, Level 2, Flinders Medical Centre, Bedford Park, SA 5042, Australia; robert.wilcox{at}health.sa.gov.au

Abstract

Objective To assess the efficacy of bilateral pedunculopontine nucleus (PPN) deep brain stimulation (DBS) as a treatment for primary progressive freezing of gait (PPFG).

Methods A patient with PPFG underwent bilateral PPN-DBS and was followed clinically for over 14 months.

Results The PPFG patient exhibited a robust improvement in gait and posture following PPN-DBS. When PPN stimulation was deactivated, postural stability and gait skills declined to pre-DBS levels, and fluoro-2-deoxy-d-glucose positron emission tomography revealed hypoactive cerebellar and brainstem regions, which significantly normalised when PPN stimulation was reactivated.

Conclusions This case demonstrates that the advantages of PPN-DBS may not be limited to addressing freezing of gait (FOG) in idiopathic Parkinson's disease. The PPN may also be an effective DBS target to address other forms of central gait failure.

Statistics from Altmetric.com

Footnotes

  • Funding This study was self-funded by the authors as an extension of the patient's clinical management and not supported by specific funding. RAW, TC and PS received financial support from Medtronic Australasia to attend the Australasian Deep Brain Stimulation Meeting in 2009.

  • Competing interests None.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.